| Aha ika | ActiTid™ e-AH3 (Liquefied 500) |
| CAS Mba. | 7732-18-5; 616204-22-9; 1117-86-8 |
| Aha INCI | Mmiri; Acetyl hexapeptide-8; Capryl glycol |
| Ngwa | Ude mmiri, Serum, nkpuchi, nhicha ihu |
| ngwugwu | 1kg / karama |
| Ọdịdị | Mmiri mmiri doro anya na nke doro anya |
| Peptide ọdịnaya | 0.045 - 0.060% |
| Mmiri na-agbaze | Mmiri soluble |
| Ọrụ | Usoro Peptide |
| Ndụ nchekwa | afọ 2 |
| Nchekwa | Chekwaa n'ebe dị jụụ na nke kpọrọ nkụ, pụọ na ìhè. 2 ~ 8 Celsius C maka nchekwa |
| Usoro onunu ogwu | 3.0-10.0% |
Ngwa
Nchọpụta n'ime usoro mgbochi mgbakasị ahụ mere ka achọpụta ActiTide ™ AH3, hexapeptide ọhụrụ mepụtara site na usoro sayensị sitere na nhazi ezi uche gaa na mmepụta GMP, yana nsonaazụ dị mma.
ActiTide ™ AH3 na-ebuga arụmọrụ na-ebelata wrinkles dị ka Botulinum Toxin Type A, ebe ọ na-ezere ihe egwu ịgba ọgwụ na-enye oke ọnụ ahịa.
Uru ịchọ mma:
ActiTide ™ AH3 na-ebelata ịdị omimi nke wrinkles na-akpata site na mkpụkọ akwara ihu, na-enwe mmetụta pụtara ìhè n'egedege ihu yana wrinkles periocular.
Usoro nke Omume:
Mkpụkpọ akwara na-apụta mgbe a tọhapụrụ neurotransmitter site na vesicles synapti. Ihe mgbagwoju anya SNARE - mgbakọ ternary nke VAMP, Syntaxin, na protein SNAP-25 - dị mkpa maka vesicle docking na neurotransmitter exocytosis (A. Ferrer Montiel et al., JBC 1997, 272: 2634-2638). Mgbagwoju anya a na-arụ ọrụ dị ka nko cellular, na-ejide vesicles na ịnya akpụkpọ anụ.
Dị ka mimetic nhazi nke SNAP-25 N-terminus, ActiTide ™ AH3 na-asọmpi na SNAP-25 maka ntinye n'ime ogige SNARE, na-emegharị mgbakọ ya. Mwepụ nke mgbagwoju SNARE na-emebi vesicle docking na ntọhapụ nke neurotransmitter na-esote, na-eduga n'ịbelata mkpụkọ akwara na mgbochi nke wrinkle na nhazi nke ọma.
ActiTide ™ AH3 bụ ihe nchekwa dị mma, nke na-echekwa akụ na ụba na nke dị nro karịa Botulinum Toxin Type A. Ọ na-elekwasị anya n'otu ụzọ ahụ na-emepụta wrinkle mana ọ na-arụ ọrụ site na usoro dị iche.
